Secretary for Health Prof Lo Chung-mau met a delegation led by Guangdong Provincial Medical Products Administration (GDMPA) General Director Jiang Xiaodong today, with both sides agreeing to further deepen collaboration in relevant areas. Prof Lo said the Hong Kong Special Administrative Region Government expressed its sincere gratitude to the GDMPA for its staunch support for Hong Kong in the past, including the implementation of the initiatives of, among others, the measure of using Hong Kong registered drugs and medical devices used in Hong Kong public hospitals in the Guangdong-Hong Kong-Macao Greater Bay Area and streamlining of the approval procedures for Hong Kong registered traditional proprietary Chinese medicines (pCms) for external use to be registered and sold in the Mainland. The Government and the GDMPA agreed at the meeting to further deepen collaboration on the regulation of Chinese medicines (CM), the formulation of Greater Bay Area Chinese medicine standards,
The Beat Drugs Fund today began inviting grant applications for its 2022 funding exercise. The application period closes on September 7.
The fund subsidises projects which tackle the problem of drug abuse.
Priority will be accorded to projects in three areas - treatment and rehabilitation, preventive education and publicity, and research.
The application form and guide are available on the Security Bureau Narcotics Division website.
The Beat Drugs Fund Association will also arrange three briefing and experience sharing sessions online on August 1, 4 and 11 for interested applicants. The online enrolment form is now available.
Application results will be released in the first quarter of next year.
http://dlvr.it/SVZkCG
http://dlvr.it/SVZkCG